Literature DB >> 21704950

Systematic review of randomized controlled trials evaluating the efficacy and safety of ginseng.

Nam-Hun Lee1, Chang-Gue Son.   

Abstract

This systematic review aims to evaluate the available evidence from randomized clinical trials of the clinical efficacy and safety of ginseng. Systematic literature searches were performed in 13 databases up to March 2009 without language restriction. All randomized clinical trials evaluating the clinical effects or safety of the use of ginseng monopreparations (Panax ginseng or P. quinquefolium) were considered for inclusion. A total of 411 potentially relevant studies were identified and 57 randomized clinical trials were included. The main indications included glucose metabolism, physical performance, psychomotor function, sexual function, cardiac function, pulmonary disease, and cerebrovascular disease. We found strong evidence of a positive effect of ginseng on glucose metabolism, psychomotor function, and pulmonary disease, whereas evidence suggests that ginseng is not effective at enhancing physical performance. However, ginseng generally has a good safety profile and the incidence of adverse effects seems to be low. In conclusion, our review compiles the evidence on the use of ginseng, finding a strong positive potential for glucose metabolism, psychomotor function, and pulmonary disease, but not for physical performance enhancement.
Copyright © 2011 Korean Pharmacopuncture Institute. Published by .. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21704950     DOI: 10.1016/S2005-2901(11)60013-7

Source DB:  PubMed          Journal:  J Acupunct Meridian Stud        ISSN: 2005-2901


  26 in total

Review 1.  Phytotherapy and Nutritional Supplements on Breast Cancer.

Authors:  C M Lopes; A Dourado; R Oliveira
Journal:  Biomed Res Int       Date:  2017-08-06       Impact factor: 3.411

Review 2.  Pharmacological properties of ginsenosides in inflammation-derived cancers.

Authors:  Do Luong Huynh; Nguyen Hoai Nguyen; Cuong Thach Nguyen
Journal:  Mol Cell Biochem       Date:  2021-04-26       Impact factor: 3.396

Review 3.  Evolution of the adaptogenic concept from traditional use to medical systems: Pharmacology of stress- and aging-related diseases.

Authors:  Alexander G Panossian; Thomas Efferth; Alexander N Shikov; Olga N Pozharitskaya; Kenny Kuchta; Pulok K Mukherjee; Subhadip Banerjee; Michael Heinrich; Wanying Wu; De-An Guo; Hildebert Wagner
Journal:  Med Res Rev       Date:  2020-10-25       Impact factor: 12.944

4.  The history of ginseng in the management of erectile dysfunction in ancient China (3500-2600 BCE).

Authors:  Rajesh Nair; Senthy Sellaturay; Seshadri Sriprasad
Journal:  Indian J Urol       Date:  2012-01

Review 5.  Pharmacological effects of ginseng on infectious diseases.

Authors:  Nguyen H Nguyen; Cuong Thach Nguyen
Journal:  Inflammopharmacology       Date:  2019-08-12       Impact factor: 5.093

Review 6.  A flood of health functional foods: what is to be recommended?

Authors:  Eun Sil Lee
Journal:  J Menopausal Med       Date:  2015-04-27

Review 7.  Review of cases of patient risk associated with ginseng abuse and misuse.

Authors:  Doo Jin Paik; Chang Ho Lee
Journal:  J Ginseng Res       Date:  2014-12-06       Impact factor: 6.060

8.  A comprehensive review of the therapeutic and pharmacological effects of ginseng and ginsenosides in central nervous system.

Authors:  Hee Jin Kim; Pitna Kim; Chan Young Shin
Journal:  J Ginseng Res       Date:  2013-03       Impact factor: 6.060

9.  Antifatigue effects of Panax ginseng C.A. Meyer: a randomised, double-blind, placebo-controlled trial.

Authors:  Hyeong-Geug Kim; Jung-Hyo Cho; Sa-Ra Yoo; Jin-Seok Lee; Jong-Min Han; Nam-Hun Lee; Yo-Chan Ahn; Chang-Gue Son
Journal:  PLoS One       Date:  2013-04-17       Impact factor: 3.240

Review 10.  Ginseng for health care: a systematic review of randomized controlled trials in Korean literature.

Authors:  Jiae Choi; Tae-Hun Kim; Tae-Young Choi; Myeong Soo Lee
Journal:  PLoS One       Date:  2013-04-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.